Astellas Pharma of Japan plans to hire 300 sales employees in China in a bid to double its China sales in five years. Although Astellas did not break out separate figures for China, its Asia revenues (including China) are expected to be $395 million this year. By the end of the March quarter in 2015, the company wants to increase that number to $670 million. More details...